Incidence and Risk of Anti-Resorptive Agent-Related Osteonecrosis of the Jaw after Tooth Extraction: A Retrospective Study

Bone-modifying agents (BMA) such as bisphosphonates and denosumab are frequently used for the treatment of bone metastases, osteoporosis, and multiple myeloma. BMA may lead to anti-resorptive agent-related osteonecrosis of the jaw (ARONJ). This study aimed to clarify the risk factors for and probabi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Healthcare (Basel) 2022-07, Vol.10 (7), p.1332
Hauptverfasser:	Shimizu, Rieko, Sukegawa, Shintaro, Sukegawa, Yuka, Hasegawa, Kazuaki, Ono, Sawako, Nakamura, Tomoya, Fujimura, Ai, Fujisawa, Ayaka, Nakano, Keisuke, Takabatake, Kiyofumi, Kawai, Hotaka, Nagatsuka, Hitoshi, Furuki, Yoshihiko
Format:	Artikel
Sprache:	eng
Schlagworte:	Anemia Breast cancer Cancer therapies Chemotherapy Diabetes Endocrine therapy Jaw Local anesthesia Maxillofacial surgery Monoclonal antibodies Patients Radiation therapy Random variables Regression analysis Risk factors Statistical analysis Surgeons Sutures Tooth extractions
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!